Trans-fatty acids and cardiovascular risk: does origin matter?

References

• Wahle KWJ, James WPT. Isomeric fatty acids and human health. Eur J Clin Nutr. 1993;47(12):828–839.
   PubMed Web of Science ®Google Scholar
• EFSA NDA Panel. Opinion of the scientific panel on dietetic products, nutrition and allergies on a request from the commission related to the presence of trans fatty acids in foods and the effect on human health of the consumption of trans fatty acids. EFSA J. 2004;81:1–49.
   Google Scholar
• Stender S, Dyerberg J. The influence of trans fatty acids on health. A report from the Danish Nutrition Council. The Danish Nutrition Council. 4th Edition, No. 34. Søborg, Denmark 2003.
   Google Scholar
• Lichtenstein AH. Dietary trans fatty acids and cardiovascular disease risk: past and present. Curr Atheroscler Rep. 2014;16(8):433.
   PubMed Web of Science ®Google Scholar
• Poudyal H, Brown L. Should the pharmacological actions of dietary fatty acids in cardiometabolic disorders be classified based on biological or chemical function? Prog Lipid Res. 2015;59:172–200.
   PubMed Web of Science ®Google Scholar
• de Souza RJ, Mente A, Maroleanu A, et al. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ. 2015;351:h3978.
   PubMed Web of Science ®Google Scholar
• Institute of Food Science and Technology (IFST). Trans fatty acids; [cited 2016 Feb 22]. Available from: http://www.ifst.org/knowledge-centre/information-statements/trans-fatty-acids.
   Google Scholar
• Restrepo BJ, Rieger M. Denmark’s policy on artificial trans fat and cardiovascular disease. Am J Prev Med. 2016;50(1):69–76.
   PubMed Web of Science ®Google Scholar
• L’Abbe MR, Stender S, Skeaff M, et al. Approaches to removing trans fats from the food supply in industrialized and developing countries. Eur J Clin Nutr. 2009;63(S2):50–67.
   Web of Science ®Google Scholar
• U.S. Department of Health and Human Services and U.S. Department of Agriculture. 2015-2020 dietary guidelines for Americans. 8th ed. 2015 Dec [cited 2016 Feb 12]. Available from: http://health.gov/dietaryguidelines/2015/guidelines/.
   Google Scholar
• Food and Drug Administration (FDA). The FDA takes step to remove artificial trans fats in processed foods; 2015 Jun 16 [cited 2016 Feb 12]. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm451237.htm.
   Google Scholar
• Restrepo BJ, Rieger M. Trans fat and cardiovascular disease mortality: evidence from bans in restaurants in New York. J Health Econ. 2016;45:176–196.
   PubMed Web of Science ®Google Scholar
• Wang Q, Afshin A, Yakoob MY, et al. Impact of nonoptimal intakes of saturated, polyunsaturated, and trans fat on global burdens of coronary heart disease. J Am Heart Assoc. 2016;5(1): pii:e002891.
   Web of Science ®Google Scholar
• Allen K, Pearson-Stuttard J, Hooton W, et al. Potential of trans fats policies to reduce socioeconomic inequalities in mortality from coronary heart disease in England: cost effectiveness modelling study. BMJ. 2015;351:h4583.
   Google Scholar
• Baer DJ. What do we really know about the health effects of natural sources of trans fatty acids? Am J Clin Nutr. 2012;95(2):267–268.
   PubMed Web of Science ®Google Scholar
• Astrup A. Yogurt and dairy product consumption to prevent cardiometabolic diseases: epidemiologic and experimental studies. Am J Clin Nutr. 2014;99(5 Suppl):1235S–1242S.
   PubMed Web of Science ®Google Scholar
• Ebringer L, Ferencík M, Krajcovic J. Beneficial health effects of milk and fermented dairy products-review. Folia Microbiol (Praha). 2008;53(5):378–394.
   PubMed Web of Science ®Google Scholar
• Jaudszus A, Kramer R, Pfeuffer M, et al. trans Palmitoleic acid arises endogenously from dietary vaccenic acid. Am J Clin Nutr. 2014;99(3):431–435.
   PubMed Web of Science ®Google Scholar
• Lacroix E, Charest A, Cyr A, et al. Randomized controlled study of the effect of a butter naturally enriched in trans fatty acids on blood lipids in healthy women. Am J Clin Nutr. 2012;95(2):318–325.
   PubMed Web of Science ®Google Scholar
• Gayet-Boyer C, Tenenhaus-Aziza F, Prunet C, et al. Is there a linear relationship between the dose of ruminant trans-fatty acids and cardiovascular risk markers in healthy subjects: results from a systematic review and meta-regression of randomised clinical trials. Br J Nutr. 2014;112(12):1914–1922.
   PubMed Web of Science ®Google Scholar
• Brouwer IA, Wanders AJ, Katan MB. Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans – a quantitative review. PLoS ONE. 2010;5(3):e9434.
   PubMed Web of Science ®Google Scholar
• Chardigny JM, Destaillats F, Malpuech-Brugère C, et al. Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans fatty acids collaboration (TRANSFACT) study. Am J Clin Nutr. 2008;87(3):558–566.
   PubMed Web of Science ®Google Scholar
• Voorrips LE, Brants HA, Kardinaal AF, et al. Intake of conjugated linoleic acid, fat, and other fatty acids in relation to postmenopausal breast cancer: the Netherlands cohort study on diet and cancer. Am J Clin Nutr. 2002;76(4):873–882.
   PubMed Web of Science ®Google Scholar
• Fritsche J, Steinhart H. Amounts of conjugated linoleic acid (CLA) in German foods and evaluation of daily intake. Zeitschr Lebensm Unters Forsch. 1998;206(2):77–82.
   Google Scholar
• Takeuchi H, Yamaki M, Hirose K, et al. Effect of a 0.6% energy trans fatty acid intake on serum cholesterol concentrations in healthy young Japanese subjects. Biosci Biotechnol Biochem. 2011;75(11):2243–2245.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Kutsuwada T, Shirokawa Y, et al. Supplementation with 1% energy trans fatty acids had little effect on serum cholesterol levels in healthy young Japanese women. Biosci Biotechnol Biochem. 2013;77(6):1219–1222.
   PubMed Web of Science ®Google Scholar
• Gebauer SK, Destaillats F, Dionisi F, et al. Vaccenic acid and trans fatty acid isomers from partially hydrogenated oil both adversely affect LDL cholesterol: a double-blind, randomized controlled trial. Am J Clin Nutr. 2015;102(6):1339–1346.
   PubMed Web of Science ®Google Scholar
• Sun Q, Ma J, Campos H, et al. A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation. 2007;115(14):1858–1865.
   PubMed Web of Science ®Google Scholar
• Chowdhury R, Warnakula S, Kunutsor S, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med. 2014;160(6):398–406.
   PubMed Web of Science ®Google Scholar
• Mozaffarian D, Cao H, King IB, et al. Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Ann Intern Med. 2010;153(12):790–799.
   PubMed Web of Science ®Google Scholar
• Mozaffarian D, De Oliveira Otto MC, Lemaitre RN, et al. trans-Palmitoleic acid, other dairy fat biomarkers, and incident diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr. 2013;97(4):854–861.
   PubMed Web of Science ®Google Scholar
• Wang Q, Imamura F, Lemaitre RN, et al. Plasma phospholipid trans-fatty acids levels, cardiovascular diseases, and total mortality: the cardiovascular health study. J Am Heart Assoc. 2014;3(4):e000914.
   Google Scholar
• Wang Q, Imamura F, Ma W, et al. Circulating and dietary trans fatty acids and incident type 2 diabetes in older adults: the Cardiovascular Health Study. Diabetes Care. 2015;38(6):1099–1107.
   PubMed Web of Science ®Google Scholar
• Takkunen MJ, Schwab US, De Mello VD, et al. DPS study group. Longitudinal associations of serum fatty acid composition with type 2 diabetes risk and markers of insulin secretion and sensitivity in the Finnish diabetes prevention study. Eur J Nutr. 2015. doi:10.1007/s00394-015-0911-4.
   PubMed Web of Science ®Google Scholar
• Kleber ME, Delgado GE, Lorkowski S, et al. Trans fatty acids and mortality in patients referred for coronary angiography: the ludwigshafen risk and cardiovascular health study. Eur Heart J. 2015. doi:10.1093/eurheartj/ehv446.
   Web of Science ®Google Scholar
• Mozaffarian D. Natural trans fat, dairy fat, partially hydrogenated oils, and cardiometabolic health: the Ludwigshafen risk and cardiovascular health study. Eur Heart J. 2015. doi:10.1093/eurheartj/ehv595.
   PubMed Web of Science ®Google Scholar
• von Schacky C, Passow A, Kiefl R. Trans-fatty acid levels in erythrocytes in Europe. Eur J Nutr. 2016. doi:10.1007/s00394-016-1218-9.
   Google Scholar
• Gijsbers L, Ding EL, Malik VS, et al. Consumption of dairy foods and diabetes incidence: a dose-response meta-analysis of observational studies. Am J Clin Nutr. 2016;103:1111–1124. doi:10.3945/ajcn.115.123216.
   PubMed Web of Science ®Google Scholar